home / stock / cvrx / cvrx news

CVRX News and Press, CVRx Inc. From 05/27/26

Stock Information
Company Name: CVRx Inc.
Stock Symbol: CVRX
Market: NASDAQ
Website: cvrx.com
Menu
Get CVRX Alerts

News, Short Squeeze, Breakout and More Instantly...
CVRX - CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that t...
CVRX - CVRx to Present at the William Blair 46th Annual Growth Stock Conference

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that t...

CVRX - CVRx rebounds as Humana issues Medicare policy for Barostim

2026-05-14 12:19:47 ET More on CVRx CVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript CVRx signals $63M-$67M 2026 revenue outlook as Category I CPT transition reshapes prior authorization dynamics CVRx sees Q1 revenue in the range of $14.7M to $14.8M Seeking...

CVRX - CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that H...
CVRX - CVRx signals $63M-$67M 2026 revenue outlook as Category I CPT transition reshapes prior authorization dynamics

2026-05-11 19:22:10 ET More on CVRx CVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript CVRx sees Q1 revenue in the range of $14.7M to $14.8M CVRx outlines $63M-$67M 2026 revenue target as Barostim adoption ac...

CVRX - CVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript

2026-05-11 19:20:44 ET CVRx, Inc. (CVRX) Q1 2026 Earnings Call May 11, 2026 4:30 PM EDT Company Participants Kevin Hykes - President, CEO & Director Jared Oasheim - Chief Financial Officer Conference Call Participants Mike Vallie - Westwicke Partner...

CVRX - CVRx (CVRX) Q1 2026 Earnings Call Transcript

2026-05-11 17:58:01 ET Image source: The Motley Fool. Monday, May 11, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
CVRX - CVRx GAAP EPS of -$0.50 in-line, revenue of $14.8M beats by $0.17M

2026-05-11 16:25:52 ET More on CVRx CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript CVRx sees Q1 revenue in the range of $14.7M to $14.8M CVRx outlines $63M-$67M 2026 revenue target as Barostim adoption accelerates with new CPT code Seeking Alpha’s ...

CVRX - CVRx Reports First Quarter 2026 Financial and Operating Results

MINNEAPOLIS, May 11, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and op...

CVRX - CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced the enrollment of the first patient in the lan...
Previous 10 Next 10